In conclusion, our study characterized inhibitory and non-inhibitory anti-properdin MoAbs, which allowed identification of a critical role of human properdin in PNH and aHUS pathogenesis in in vitro models developed in our laboratory. The gene discussed is CFP; the disease is paroxysmal nocturnal hemoglobinuria.